| Literature DB >> 14712313 |
Dariusz W Kowalczyk1, Anthony P Wlazlo, Wynetta Giles-Davis, Andreas R Kammer, Sunil Mukhopadhyay, Hildegund C J Ertl.
Abstract
Data presented here demonstrate that vaccine-induced CD8(+) T cells can eliminate their specific tumor-target with a two-staged attack. First, they release interferon-gamma that results in growth arrest of the tumor cells via induction of antiangiogenic mediators. Then, during the latter stages of the immune response, CD8(+) effector T cells eradicate the remaining tumor cells through perforin-mediated lysis. A combination of these two mechanisms is highly effective in the described model, while either pathway alone fails to completely achieve tumor rejection.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14712313 DOI: 10.1038/sj.cgt.7700653
Source DB: PubMed Journal: Cancer Gene Ther ISSN: 0929-1903 Impact factor: 5.987